Table 2.
Summary of findings from astrocytic RNA sequencing studies. Marker genes in bold are increased. Marker genes that are only italicized are decreased. WT: Wild-type.
Experiment | Species & Tissue Location | Disease State | Marker Gene(S) | Pathways | Reference |
---|---|---|---|---|---|
Single-nucleus RNA-seq | Human prefrontal cortex | AD | MT2A, MT1E, GJA1, LINGO1, RASGEF1B | Protein localisation, protein translation, protein stabilisation | [33] |
Single-cell RNA-seq | Mouse brainstem | ALS | Mt1, Mt2, Fam107a, Malat1 | Neurogenesis, regulation of cell projection organization, neuron differentiation | [35] |
Single-cell RNA-seq | Mouse cortical layers | WT | Unc13c | Insulin signaling | [76] |
Single-cell RNA-seq | Mouse cortex and hippocampus | WT | Agt, Gfap, Unc13c | Transcription regulators | [76] |
Single-cell RNA-seq | Mouse hippocampus | WT | Frzb, Ascl1 | Mitosis and cell cycle regulation, neural tissue development | [76] |
Single-cell RNA-seq | Mouse cortex and hippocampus | WT | Fam107a | Glucose metabolism, energy production, neural tissue development | [76] |
Single-cell RNA-seq | Mouse hippocampus | WT | Gfap, Agt | Synaptogenesis, synaptic plasticity, glutamatergic neurotransmission | [76] |
Single-cell RNA-seq | Mouse brain | LPS treatment | Serpina3n | Adaptive immune response, NF-kB signalling | [77] |
Single-nucleus RNA-seq | Human prefrontal cortex | AD | ADGRV1, GPC5, RYR3 | Synaptic signaling, glutamate secretion | [78] |